|

SPH4336 Tablets Placebo Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2/3: 2

Top Sponsors

  • Shanghai Pharmaceuticals Holding Co., Ltd2

Indications

  • Locally Advanced or Metastatic Breast Cancer2
  • Breast Cancer2
  • Cancer2

Other2 trials

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Phase 2/3
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.